PALO
ALTO, Calif., Nov. 16,
2022 /PRNewswire/ -- Kodiak Sciences Inc.
(NASDAQ: KOD), a biopharmaceutical company committed to
researching, developing and commercializing transformative
therapeutics to treat high prevalence retinal diseases, announced
today that management will present virtually at the Evercore ISI
5th Annual HealthCONx Conference on Tuesday, November 29, 2022, at 9:10am Pacific Time (12:10pm Eastern Time).
A live webcast of the presentation will be available on the
"Events and Presentations" section of Kodiak's website at
http://ir.kodiak.com/ and will remain available for replay for
a limited time following the event.
About Kodiak Sciences
Inc.
Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to
researching, developing and commercializing transformative
therapeutics to treat high prevalence retinal diseases. Founded in
2009, we are focused on bringing new science to the design and
manufacture of next generation retinal medicines to prevent and
treat the leading causes of blindness globally. Our ABC
Platform™ uses molecular engineering to merge the fields
of antibody-based and chemistry-based therapies and is at the core
of Kodiak's discovery engine. Kodiak's lead product candidate,
tarcocimab tedromer, is a novel anti-VEGF antibody biopolymer
conjugate being developed for the treatment of retinal vascular
diseases including wet age-related macular degeneration, the
leading cause of blindness in elderly patients in the developed
world, and diabetic eye diseases, the leading cause of blindness in
working-age patients in the developed world. Kodiak has leveraged
its ABC Platform to build a pipeline of product candidates in
various stages of development. KSI-501 is our dual inhibitor
antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and
IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases. We
are expanding our early research pipeline to include ABC Platform
based triplet inhibitors for multifactorial retinal diseases such
as dry AMD and glaucoma. Kodiak is based in Palo Alto, CA. For more information, please
visit www.kodiak.com.
Kodiak®, Kodiak Sciences®,
ABC™, ABC Platform™ and the Kodiak logo are
registered trademarks or trademarks of Kodiak Sciences Inc. in
various global jurisdictions.
View original
content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-the-evercore-isi-5th-annual-healthconx-conference-301680614.html
SOURCE Kodiak Sciences Inc.